Wieslander J - Search Results

1

Molecular mapping of the Goodpasture's epitope for glomerulonephritis.

Bolton WK, Chen L, Hellmark T, Fox J, Wieslander J. Bolton WK, et al. Among authors: wieslander j. Trans Am Clin Climatol Assoc. 2005;116:229-36; discussion 237-8. Trans Am Clin Climatol Assoc. 2005. PMID: 16555617 Free PMC article.

2

Epitope spreading and autoimmune glomerulonephritis in rats induced by a T cell epitope of Goodpasture's antigen.

Bolton WK, Chen L, Hellmark T, Wieslander J, Fox JW. Bolton WK, et al. Among authors: wieslander j. J Am Soc Nephrol. 2005 Sep;16(9):2657-66. doi: 10.1681/ASN.2004100823. Epub 2005 Jul 27. J Am Soc Nephrol. 2005. PMID: 16049074

3

Immunodominant epitopes of alpha3(IV)NC1 induce autoimmune glomerulonephritis in rats.

Chen L, Hellmark T, Wieslander J, Bolton WK. Chen L, et al. Among authors: wieslander j. Kidney Int. 2003 Dec;64(6):2108-20. doi: 10.1046/j.1523-1755.2003.00332.x. Kidney Int. 2003. PMID: 14633133 Free article.

4

The prognostic significance in Goodpasture's disease of specificity, titre and affinity of anti-glomerular-basement-membrane antibodies.

Segelmark M, Hellmark T, Wieslander J. Segelmark M, et al. Among authors: wieslander j. Nephron Clin Pract. 2003;94(3):c59-68. doi: 10.1159/000072022. Nephron Clin Pract. 2003. PMID: 12902632

5

Point mutations of single amino acids abolish ability of alpha3 NC1 domain to elicit experimental autoimmune glomerulonephritis in rats.

Hellmark T, Chen L, Ohlsson S, Wieslander J, Bolton WK. Hellmark T, et al. Among authors: wieslander j. J Biol Chem. 2003 Nov 21;278(47):46516-22. doi: 10.1074/jbc.M211951200. Epub 2003 Sep 11. J Biol Chem. 2003. PMID: 12970356 Free article.

6

Characterization of anti-GBM antibodies involved in Goodpasture's syndrome.

Hellmark T, Johansson C, Wieslander J. Hellmark T, et al. Among authors: wieslander j. Kidney Int. 1994 Sep;46(3):823-9. doi: 10.1038/ki.1994.338. Kidney Int. 1994. PMID: 7527877 Free article.

7

Identification of a clinically relevant immunodominant region of collagen IV in Goodpasture disease.

Hellmark T, Segelmark M, Unger C, Burkhardt H, Saus J, Wieslander J. Hellmark T, et al. Among authors: wieslander j. Kidney Int. 1999 Mar;55(3):936-44. doi: 10.1046/j.1523-1755.1999.055003936.x. Kidney Int. 1999. PMID: 10027930 Free article.

8

Goodpasture disease. Characterization of a single conformational epitope as the target of pathogenic autoantibodies.

Hellmark T, Burkhardt H, Wieslander J. Hellmark T, et al. Among authors: wieslander j. J Biol Chem. 1999 Sep 3;274(36):25862-8. doi: 10.1074/jbc.274.36.25862. J Biol Chem. 1999. PMID: 10464328 Free article.

9

Molecular properties of the Goodpasture epitope.

Gunnarsson A, Hellmark T, Wieslander J. Gunnarsson A, et al. Among authors: wieslander j. J Biol Chem. 2000 Oct 6;275(40):30844-8. doi: 10.1074/jbc.M004717200. J Biol Chem. 2000. PMID: 10896942 Free article.

10

Patients with Goodpasture's disease have two normal COL4A3 alleles encoding the NC1 domain of the type IV collagen alpha 3 chain.

Persson U, Hertz JM, Carlsson M, Hellmark T, Juncker I, Wieslander J, Segelmark M. Persson U, et al. Among authors: wieslander j. Nephrol Dial Transplant. 2004 Aug;19(8):2030-5. doi: 10.1093/ndt/gfh355. Epub 2004 Jun 15. Nephrol Dial Transplant. 2004. PMID: 15199166

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

214 results

Search Page

Filters